NYSE · BHVN
Healthcare · Biotechnology
$15.41
Down-$0.71 (-4.40%)
Updated Aug 29, 2026, 4:50 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
BHVN closed at $15.41 after 21 trading sessions, up 14.15% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $15.88 | $16.34 | $14.94 | $15.41 | 2.89M |
| Aug 27, 2026 | $16.95 | $17.05 | $15.50 | $16.12 | 5.43M |
| Aug 26, 2026 | $14.24 | $18.24 | $13.00 | $16.95 | 15.77M |
| Aug 25, 2026 | $13.96 | $14.86 | $13.92 | $14.38 | 3.44M |
| Aug 24, 2026 | $13.95 | $14.00 | $13.56 | $13.68 | 1.36M |
| Aug 21, 2026 | $13.60 | $14.33 | $13.53 | $13.85 | 2.09M |
| Aug 20, 2026 | $13.96 | $14.52 | $13.26 | $13.50 | 4.02M |
| Aug 19, 2026 | $13.94 | $14.44 | $13.76 | $14.14 | 1.96M |
| Aug 18, 2026 | $14.30 | $14.30 | $13.545 | $13.57 | 1.97M |
| Aug 17, 2026 | $14.50 | $14.79 | $14.22 | $14.46 | 1.85M |
| Aug 14, 2026 | $14.79 | $14.96 | $14.31 | $14.64 | 1.24M |
| Aug 13, 2026 | $14.47 | $15.04 | $14.30 | $14.85 | 1.65M |
| Aug 12, 2026 | $14.63 | $14.75 | $14.18 | $14.39 | 2.14M |
| Aug 11, 2026 | $14.00 | $14.57 | $13.73 | $14.49 | 2.36M |
| Aug 10, 2026 | $14.59 | $14.92 | $14.50 | $14.54 | 1.38M |
| Aug 7, 2026 | $14.77 | $14.93 | $14.44 | $14.66 | 1.12M |
| Aug 6, 2026 | $13.61 | $14.505 | $13.61 | $14.42 | 1.88M |
| Aug 5, 2026 | $13.82 | $14.00 | $13.425 | $13.63 | 1.43M |
| Aug 4, 2026 | $13.66 | $13.785 | $13.32 | $13.75 | 2.41M |
| Aug 3, 2026 | $13.51 | $13.70 | $13.13 | $13.37 | 1.59M |
| Jul 31, 2026 | $13.87 | $13.94 | $13.2527 | $13.50 | 1.43M |
The latest Smart Investors Daily articles mentioning BHVN.
BHVN research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
1 matching article.
Benzinga · Aug 25, 2026
Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE:BHVN) and Yale University ("Yale") today announced that the U.S. District Court for the District of Delaware has entered judgment in
The latest Smart Investors Daily articles mentioning BHVN.
